(Q33489423)

27 July 2017

Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi's sarcoma in an AIDS patient (English)

1 reference

27 July 2017

1 reference

H Albrecht

1

1 reference

27 July 2017

H J Stellbrink

2

1 reference

27 July 2017

G Gross

3

1 reference

27 July 2017

B Berg

4

1 reference

27 July 2017

U Helmchen

5

1 reference

27 July 2017

H Mensing

6

1 reference

27 July 2017

1 December 1994

1 reference

Journal of Molecular Medicine

27 July 2017

1 reference

27 July 2017

72

1 reference

27 July 2017

12

1 reference

27 July 2017

1041-1047

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00577752

27 July 2017

0 references

cites work

A phase I trial of recombinant human interferon-gamma in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS).

1 reference

12 December 2020

[Leishmaniasis of the upper gastrointestinal tract in an HIV positive patient]

1 reference

12 December 2020

Visceral leishmaniasis (kala azar) in a patient with AIDS

1 reference

12 December 2020

Gastric localization of systemic leishmaniasis in a patient with AIDS

1 reference

12 December 2020

Visceral leishmaniasis (kala-azar) in acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma

1 reference

12 December 2020

Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain

1 reference

12 December 2020

Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection

1 reference

12 December 2020

Use of IFN-gamma in patients with AIDS

1 reference

12 December 2020

Asymptomatic visceral leishmaniasis in a patient with acquired immunodeficiency syndrome

1 reference

12 December 2020

New perspectives on a subclinical form of visceral leishmaniasis

1 reference

12 December 2020

Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

1 reference

12 December 2020

Treatment of AIDS-related Kaposi's sarcoma with recombinant gamma-interferon

1 reference

12 December 2020

Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature

1 reference

12 December 2020

Atopic manifestations in the acquired immune deficiency syndrome: response to recombinant interferon gamma

1 reference

12 December 2020

Immunotherapy for parasitic disease

1 reference

12 December 2020

Disseminated-to-skin kala-azar and the acquired immunodeficiency syndrome

1 reference

12 December 2020

Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine

1 reference

12 December 2020

Rectal leishmaniasis in a patient with acquired immunodeficiency syndrome

1 reference

12 December 2020

Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS.

1 reference

12 December 2020

Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony

1 reference

12 December 2020

Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: induction of microbicidal activity by interferon-gamma

1 reference

12 December 2020

Progression of Kaposi's sarcoma under a combined interferon beta and interferon gamma therapy in AIDS patients

1 reference

12 December 2020

Visceral leishmaniasis in immunocompromised hosts

1 reference

12 December 2020

Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma

1 reference

12 December 2020

Fatal leishmaniasis in renal-transport patient

1 reference

12 December 2020

Visceral leishmaniasis involving lung and a cutaneous Kaposi's sarcoma lesion.

1 reference

12 December 2020

Small intestinal involvement in visceral leishmaniasis

1 reference

12 December 2020

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis

1 reference

12 December 2020

Visceral leishmaniasis in HIV-infected patients

1 reference

12 December 2020

AIDS-associated leishmaniasis: an unusual gastro-duodenal presentation

1 reference

12 December 2020

Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV).

1 reference

12 December 2020

Therapeutic trial of interferon-gamma in patients with epidemic Kaposi's sarcoma

1 reference

12 December 2020

Interferon-gamma associated with conventional therapy for recurrent visceral leishmaniasis in a patient with AIDS.

1 reference

12 December 2020

[HIV infection and kala-azar]

1 reference

12 December 2020

Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients.

1 reference

12 December 2020

Visceral leishmaniasis in an HIV-infected patient: clinical features and response to treatment

1 reference

12 December 2020

Marked disparity in incidence of bacterial infections in patients with the acquired immunodeficiency syndrome receiving interleukin-2 or interferon-gamma

1 reference

12 December 2020

Asymptomatic leishmaniasis in the acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Immunosuppression in Kenyan visceral leishmaniasis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00577752

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference